In this issue:
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for advanced papillary RCC
Outcomes of patients with mRCC treated with targeted therapy
Pazopanib vs placebo after nephrectomy in patients with advanced RCC
Frailty predicts outcome of partial nephrectomy
Clinical, surgical, pathological and follow-up features of patients with Von Hippel-Lindau syndrome
The spinal distribution of metastatic RCC
Is partial nephrectomy safe and effective in frail comorbid patients with RCC?
Coffee consumption and risk of RCC
CLEAR study: First-line treatment for patients with advanced RCC
MK-6482 in combination with cabozantinib in advanced ccRCC
Please login below to download this issue (PDF)